[1]
Wang, C.-Y. et al. 2025. Thrombosis and bleeding outcomes with warfarin conversion to rivaroxaban during the COVID-19 pandemic. South African Medical Journal. 115, 9 (Oct. 2025), e3503. DOI:https://doi.org/10.7196/SAMJ.2025.v115i9.3503.